BRTXBioRestorative Therapies, Inc.

Nasdaq biorestorative.com


$ 1.38 $ -0.09 (-6.51 %)    

Friday, 03-May-2024 10:22:30 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 1.365
$ 1.38
$ 0.00 x 0
$ 0.00 x 0
$ 1.38 - $ 1.38
$ 1.20 - $ 7.13
77,372
na
5.76M
$ 4,864.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-27-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-30-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 04-30-2021 12-31-2020 10-K
14 04-12-2021 06-30-2020 10-Q
15 04-12-2021 09-30-2020 10-Q
16 03-29-2021 03-31-2020 10-Q
17 03-18-2021 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-Q
21 03-29-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 04-02-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 03-22-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-13-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-23-2015 09-30-2015 10-Q
35 08-14-2015 06-30-2015 10-Q
36 05-15-2015 03-31-2015 10-Q
37 03-31-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-14-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Market-Moving news for April 16th
04/16/2024 12:36:44

CGEM: 23% | Cullinan Therapeutics To Pursue Development Of CLN-978 In Autoimmune Diseases, With Systemic Lupus Erythematosus As...

 dominari-holdings-and-2-other-stocks-under-3-insiders-are-buying

The Dow Jones index closed lower by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their con...

 biorestorative-therapies-partners-with-galen-patient-recruitment-to-accelerate-completion-of-enrollment-in-phase-2-trial-of-brtx-100-in-chronic-lumbar-disc-disease

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical st...

 porch-group-and-2-other-stocks-under-3-insiders-are-buying

The Dow Jones index closed lower by more than 50 points on Friday. When insiders purchase or sell shares, it indicates their co...

 nasdaq-down-50-points-willis-towers-watson-posts-upbeat-profit

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow tra...

 why-fmc-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fo...

 crude-oil-gains-1-centene-sales-top-views

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 50 points on Tuesday. The Dow tra...

 why-biorestorative-therapies-brtx-stock-is-down-55

BioRestorative Therapies shares are trading lower by 55% during Tuesday's session. The company announced agreements with ce...

 dow-jumps-over-100-points-eli-lilly-posts-upbeat-earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market...

 biorestorative-therapies-announces-exercise-of-warrants-and-issuance-of-new-warrants-in-a-private-placement-for-81m-gross-proceeds-priced-at-the-market

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (NASDAQ:BRTX), a clinical stage company focu...

 why-biorestorative-therapies-stock-is-up-today

BioRestorative Therapies presented the data at the Orthopaedic Research Society 2024 Annual Meeting on Sunday and hosted a webc...

Core News & Articles

FDMT: 86% | 4DMT Presents Interim Data From Randomized Phase 2 PRISM Clinical Trial Of Intravitreal 4D-150 Demonstrating Favora...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION